ORAGENICS INC(OGEN)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

ORAGENICS INC (OGEN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. OGEN is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $1.4m in revenue and is scored on the micro-cap board instead. Top institutional holders of OGEN by reported 13-F value include GEODE CAPITAL MANAGEMENT, 25, JANE STREET GROUP, based on the most recent SEC filings. OGEN trades on the NYSE exchange and files with the SEC under CIK 1174940. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ORAGENICS INC directly from SEC EDGAR.

Net Income

$-2.5M

OGEN key financials by period

ORAGENICS INC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202310-K$37.7K$-20.7M—
FY 202210-K$131.5K$-14.3M—
FY 202110-K/A$87.0K$-15.7M—
FY 201410-K$939.9K$-5.8M—
FY 201310-K$1.0M$-16.1M—
FY 201210-K$1.3M$-13.1M—

Institutions holding OGEN

Institutional investors reporting a position in ORAGENICS INC on SEC Form 13F.
InstitutionSharesValueReported
GEODE CAPITAL MANAGEMENT23,685$13.8K2026-06-30
2523,160$13.4K2026-06-30
JANE STREET GROUP12,771$7.4K2026-06-30
Tower Research Capital (TRC)4,548$2.6K2026-06-30
St. Johns Investment Management Company1,924$1.1K2026-06-30
BlackRock703$408.002026-06-30
UBS Group AG642$373.002026-06-30
HARBOUR INVESTMENTS34$20.002026-06-30
WELLS FARGO & COMPANY34$20.002026-06-30
SBI Securities , Ltd.23$13.002026-06-30
SEC EDGAR: CIK 1174940 →
OGEN

ORAGENICS INC

OGEN
NYSESmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $1.4M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-2.53M

EPS (Diluted)

Q2 2026
EDGAR

$-0.57

Top Institutional Holders

as of Q2 2026
$39.2K total
GEODE CAPITAL MANAGEMENT, LLC
$13.8K-63.6%
25 LLC
$13.4KNew
JANE STREET GROUP, LLC
$7.4KNew
Tower Research Capital LLC (TRC)
$2.6K0.0%
St. Johns Investment Management Company, LLC
$1.1K+862.0%
BlackRock, Inc.
$4080.0%
UBS Group AG
$373-87.7%
HARBOUR INVESTMENTS, INC.
$200.0%
WELLS FARGO & COMPANY/MN
$200.0%
SBI Securities Co., Ltd.
$13+109.1%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…